US equities |
MU $1,088.00 ▲+0.00% META $721.31 ▲+0.00% GOOGL $350.50 ▲+0.00% SNDK $1,692.42 ▲+0.00% NVDA $237.47 ▲+0.00% INTC $113.12 ▲+0.00% AMD $645.86 ▲+0.00% JPM $329.58 ▲+0.00%
FinancialContent

Articles published by Protagonist Therapeutics

News headline image
Protagonist Therapeutics Announces $300 Million Share Repurchase Program
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics to Participate in Two Investment Bank Conferences in September 2026
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Reports Granting of Inducement Awards
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Reports Granting of Inducement Awards
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Reports Granting of Inducement Awards
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Reports Granting of Inducement Awards
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX
News headline image
Protagonist Therapeutics Reports Granting of Inducement Awards
From Protagonist Therapeutics
Via ACCESS Newswire
Tickers PTGX